Development of an immunoassay for quantification of soluble human CD40L (CD154) in plasma and serum samples

被引:0
|
作者
Pedersen, Kathrine [1 ]
Laursen, Nick Stub [1 ,2 ]
Hansen, Annette Gudmann [1 ]
Palarasah, Yaseelan [3 ]
Thiel, Steffen [1 ]
机构
[1] Aarhus Univ, Dept Biomed, Aarhus, Denmark
[2] Commit Biol, Aarhus, Denmark
[3] Univ Southern Denmark, Dept Mol Med, Odense, Denmark
基金
新加坡国家研究基金会;
关键词
Soluble CD40L; CD154; CD40:CD40L pathway; Immunoassay; Biomarker; LIGAND; LUPUS; EXPRESSION; MECHANISM; CELLS;
D O I
10.1016/j.jim.2024.113710
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
When the membrane protein CD40 ligand (CD40L) on activated T cells binds the receptor CD40 on B-cells, it provides a co-stimulatory signal for B cell activation. Dysregulation of the CD40L:CD40 axis is associated with inflammatory and autoimmune diseases. The presence of soluble CD40L (sCD40L) in plasma is implicated in several diseases, from cardiovascular and autoimmune diseases to different types of cancer, and sCD40L has been suggested as a valuable marker of disease. If sCD40L is to be used as a biomarker, being able to precisely measure and quantify the levels of sCD40L in human blood samples is of utmost importance. We demonstrate the development of a sandwich-type time-resolved immunofluorometric assay for quantification of sCD40L in plasma or serum samples. For this, we generate 29 monoclonal anti-CD40L antibodies, and from these, we select the optimal combination of capture antibody and detection antibody. A number of variables were tested: the influence of the type of sample (comparing 3 different blood collection tubes for serum sampling and 4 different types of tubes for plasma sampling), the influence of freeze-thaw cycles, the influence of sampling time during night and day, and the influence of centrifugation of the samples. We found a very similar level of sCD40L in paired EDTA plasma and serum samples. Out of 100 healthy blood donor samples 61 had a level of sCD40L below the detection level of the assay, whereas the remaining 39 samples had ranging levels of sCD40L from 1.14 to 33.14 ng/mL. In summary, we present a time-resolved immunofluorometric assay based on paired monoclonal antibodies, ensuring high specificity, sensitivity, and homogeneity. The Eu3+-based assay additionally provides consistent assay readouts due to the extended decay time not seen in standard enzyme-linked immunosorbent assays. The assay paves the way for specific and consistent quantification of sCD40L in human plasma and serum samples.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] T cells from patients with psoriatic arthritis (PSA) overexpress CD40L (CD154)
    Liossis, S. C.
    Daoussis, D.
    Antonopoulos, I.
    Andonopoulos, A. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 533 - 533
  • [22] Expression of CD154 (CD40L) on stimulated T lymphocytes in patients with idopathic thrombocytopenic purpura
    Song, Ikchan
    Kim, Jimyung
    Kwon, Kyechul
    Koo, Sunhoe
    Jo, Dukyeon
    HEMATOLOGY, 2016, 21 (03) : 187 - 192
  • [23] Elevated plasma CD40L (CD154) level reflects increased intravascular platelet activation in patients with systemic sclerosis
    Kowal-Bielecka, O.
    Kowal, K.
    Jafiszow, U.
    Bielecki, M.
    Chwiecko, J.
    Chwiesko, S.
    Bodzenta-Lukaszyk, A.
    Skowronski, J.
    Sierakowski, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 396 - 396
  • [24] The soluble active component of CD154 (CD40L)inhibits alloimmunization in humanized severe combined immune deficient mice.
    Lazarus, AH
    Freedman, J
    Crow, AR
    TRANSFUSION, 1999, 39 (10) : 98S - 98S
  • [25] CD40/CD40L (CD154) blockade alone is sufficient to prevent islet allograft rejection in the rat.
    Kover, K
    Geng, Z
    Hess, D
    Moyer, C
    Benjamin, CD
    Moore, WV
    TRANSPLANTATION, 1999, 67 (07) : S227 - S227
  • [26] Growth inhibition of human multiple myeloma cells by a CD40 ligand (CD40L, CD154) transgene - Oncolytic virus construct.
    Rodrigues, Margret S.
    Gomes, Erica M.
    Hernandez, Reuben
    Chang, Jack
    Kansopon, Joe
    Newman, Joseph
    Stone, Marvin J.
    Tong, Alex W.
    BLOOD, 2006, 108 (11) : 978A - 978A
  • [27] CD40L expression in plasma of volunteers following LPS administration: A comparison between assay of CD40L on platelet microvesicles and soluble CD40L
    Mobarrez, Fariborz
    Sjovik, Carolina
    Soop, Anne
    Hallstrom, Lars
    Frostell, Claes
    Pisetsky, David S.
    Wallen, Hakan
    PLATELETS, 2015, 26 (05) : 486 - 490
  • [28] CD154 (CD40L): A novel aid to document nonimmediate hypersensitivity to amoxicillin or amoxicillin clavulanic acid
    Van Gasse, Athina L.
    Ebo, Didier G.
    Mertens, Christel M.
    Bridts, Chris H.
    Elst, Jessy
    De Puysseleyr, Leander
    Faber, Margaretha A.
    Hagendorens, Margo M.
    De Clerck, Luc S.
    Sabato, Vito
    CLINICAL AND EXPERIMENTAL ALLERGY, 2020, 50 (05): : 640 - 642
  • [29] Differences of soluble CD40L in sera and plasma: Implications on CD40L assay as a marker of thrombotic risk
    Ahn, ER
    Lander, G
    Jy, W
    Bidot, CJ
    Jimenez, JJ
    Horstman, LL
    Ahn, YS
    THROMBOSIS RESEARCH, 2004, 114 (02) : 143 - 148
  • [30] Transforming growth factor β enhances the expression of CD154 (CD40L) and production of tumor necrosis factor α by human T lymphocytes
    Gray, JD
    Liu, TF
    Huynh, N
    Horwitz, DA
    IMMUNOLOGY LETTERS, 2001, 78 (02) : 83 - 88